What is Orbita?
Founded in 2015 and headquartered in Boston, Massachusetts, Orbita specializes in delivering sophisticated conversational AI solutions tailored for the unique needs of the healthcare and life sciences industries. Their platform enables voice and chat interactions, aiming to enhance patient engagement, streamline clinical workflows, and improve data accessibility within these critical sectors. The company's focus on a niche yet rapidly expanding market highlights its strategic positioning to leverage AI for transformative healthcare outcomes.
How much funding has Orbita raised?
Orbita has raised a total of $18.4M across 3 funding rounds:
Debt
$350K
Unspecified
$9M
Unspecified
$9M
Debt (2020): $350K with participation from PPP
Unspecified (2020): $9M led by HealthX Ventures, Newark Venture Partners, Cultivation Capital, and Philips Health Technology Ventures
Unspecified (2022): $9M supported by HealthX Ventures, Philips Health Technology Ventures, Newark Venture Partners, and Cultivation Capital
Key Investors in Orbita
HealthX Ventures
HealthX Ventures is a venture capital firm that invests in innovative companies focused on digital health solutions aimed at making healthcare more accessible, efficient, and affordable. Based in Madison, WI, the firm is led by experienced entrepreneurs and investors who provide operational support and industry knowledge to their portfolio companies.
Philips Health Technology Ventures
Philips Health Technology Ventures is an investment arm focused on backing companies that are developing groundbreaking technologies to improve health outcomes and the delivery of care.
Cultivation Capital
Cultivation Capital is a venture capital firm that invests in young companies with transformative ideas across various industries, including life sciences, software, agriculture, and geospatial technology. The firm provides capital resources and a vast network of partners to help startups navigate the challenges of hyper growth from Series Seed through Series B.
What's next for Orbita?
With the recent major strategic investment, Orbita is poised to further enhance its AI capabilities and expand its market reach. The enterprise-level funding suggests a focus on scaling operations, advancing product development, and potentially forging deeper partnerships within the healthcare ecosystem. This capital infusion will likely enable Orbita to solidify its competitive advantage, invest in research and development for next-generation AI solutions, and capitalize on the increasing digital transformation within healthcare and life sciences.
See full Orbita company page
